Demographic and clinical characteristics at inclusion of individuals with sarcoidosis and their matched general population comparators

SarcoidosisGeneral population
Subjects n873786 376
Age years49.8±14.849.8±14.7
Born in non-Nordic country#9.511.8
Education attained years
History of comorbidity
 Congestive heart disease2.41.3
 Atrial fibrillation3.22.1
 Acute myocardial infarction2.11.8
 Diabetes mellitus7.54.2
 Autoimmune disease7.94.3
 Primary immunodeficiency0.40.1
Serious infection in the past year3.90.8
≥1 medication dispensed in the past 6 monthsn=6723n=66 441
 Systemic corticosteroids18.72.9
 Other immunosuppressants+1.20.7
 Inhaled corticosteroids7.31.9

Data are presented as mean±sd or %, unless otherwise stated. Percentages may not sum to 100 owing to rounding. NSAIDs: nonsteroidal anti-inflammatory drugs. #: Nordic countries: Sweden, Denmark, Norway, Finland and Iceland (category excludes missing <0.5%); : ascertained in individuals who entered the cohort starting January 1, 2006 for whom medication dispensations could be obtained from the Prescribed Drug Register; +: includes methotrexate, azathioprine and leflunomide; §: includes antibacterial, antimycobacterial, antifungal and antiviral medications.